期刊文献+

PTTG、bFGF和MMP-9的表达与垂体腺瘤侵袭性的关系 被引量:4

Relationship between the expressions of PTTG, bFGF and MMP-9 and the invasiveness of pituitary adenomas
原文传递
导出
摘要 目的通过对垂体瘤转化基因(PTTG)、碱性成纤维细胞生长因子(bFGF)和基质金属蛋白酶-9(MMP-9)mRNA和蛋白在垂体腺瘤表达水平的检测和相关性分析,探讨PrTG、bFGF和MMP-9的表达与垂体腺瘤侵袭性的关系。方法30例垂体腺瘤手术标本分为侵袭组和非侵袭组,逆转录聚合酶链反应(RT-PCR)检测PTTG、bFGF和MMP-9mRNA的表达,免疫组化检测PTTG、bFGF和MMP-9蛋白的表达,分析侵袭组和非侵袭组PTTG、bFGF和MMP-9mRNA和蛋白的表达差异及三者之间的相关性。结果侵袭组垂体腺瘤PTTG、bFGF和MMP-9mRNA和蛋白表达均较非侵袭组增高,差异有显著性意义(P〈0.01)。相关性分析显示,PTTG、bFGF与MMP-9mRNA和蛋白表达相互之间均呈正相关(P〈0.01)。结论结合本实验结果及文献资料,我们认为PTTG→bFGF→MMP-9→肿瘤细胞外基质屏障突破这一调节通路可能是垂体腺瘤侵袭性产生的重要机制之一。 Objective To study the mRNA and protein expressions of pituitary tumor transforming gene (PTTG), basic fibroblast growth factor (bFGF) and matrix metalloproteinase 9 (MMP-9) in pituitary adenomas and to explore the association between the expressions and the invasiveness of pituitary adenomas. Methods The mRNA and protein expressions of PTTG, bFGF and MMP-9 were respectively determined by reverse transcription PCR (RT-PCR) and immunohistochemistry in 30 patients with pituitary adenomas who were divided into invasive and non-invasive groups. The difference in the expressions between the 2 groups and the correlation among the expressions were analyzed. Results The mRNA and protein expressions of PTTG, bFGF and MMP-9 were significantly higher in invasive group than those in non-invasive group (P〈0.01). The positive relation was found among the mRNA and protein expressions of PTTG, bFGF and MMP-9 (P〈 0.01). Conclusion The PTTG→bFGF→MM -9 pathway may play an important role in breaking down extracellular matrix and increasing the invasiveness of pituitary adenomas.
出处 《中华神经医学杂志》 CAS CSCD 2007年第3期282-285,共4页 Chinese Journal of Neuromedicine
  • 相关文献

参考文献12

  • 1文路,陈凌,刘运生.碱性成纤维细胞生长因子与垂体腺瘤增殖及侵袭能力的关系[J].湖南医科大学学报,2001,26(5):466-468. 被引量:3
  • 2Kawamoto H, Uozumi T, Kawamoto K, et al. Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas[J]. Acta Neurochir (Wien), 1996, 138(4): 390-395.
  • 3Hardy J, Vezina JL. Transsphenoidal neurosurgery ofintracranial neoplasm[J]. Adv Neurol, 1976, 15: 261-273.
  • 4Knosp E, Steincr E, Kitz K, et al. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings [J]. Neurosurgery,1993, 33(4): 610-618.
  • 5Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha-ms oncogene product in normal, benign, and malignant human pancreatic tissues[J]. Hum Pathol, 1990, 21(6): 607-612.
  • 6Kim DS, Franklyn JA, Stratford AL, et al. Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer [J]. J Clin Endocrinol Metab,2006, 91(3): 1119-1128.
  • 7Boelaert K, Tannahill LA, Bulmer JN, et al. A potential role for PTTG/securin in the developing human fetal brain [J]. FASEB J,2003, 17(12): 1631-1639.
  • 8Tsai S J, Lin S J, Cheng YM, et al. Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas [J]. J Clin Endocrinol Metab, 2005, 90(6):3715-3723.
  • 9Miyake H, Yoshimura K, Hara I, et al. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines [J]. J Urol, 1997,157(6): 2351-2355.
  • 10Liu JF, Crepin M, Liu JM, et al. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway [J]. Biochem Biophys Res Commun, 2002, 293(4): 1174-1182.

二级参考文献5

  • 1Zhang X,J Clin Endoc Metab,1999年,84卷,761页
  • 2Zhang X,Mol Endocrinol,1999年,13卷,156页
  • 3Heaney A P,Nat Med,1999年,5卷,1317页
  • 4Pei L,Mol Endocrinol,1997年,11卷,433页
  • 5Yaohua L,J Clin Endoc Metab,1992年,75卷,1436页

共引文献2

同被引文献57

  • 1聂新民,桂嵘,李登清,周鸣,黄祖发,李桂源.新克隆的基因NOR_1对鼻咽癌细胞株HNE_1细胞生长的影响[J].生物化学与生物物理进展,2005,32(8):777-780. 被引量:10
  • 2傅锦芳,李登清,桂嵘,聂新民,黄民主.NOR_1基因真核表达载体的构建及其对肝癌细胞生长的影响[J].中华检验医学杂志,2005,28(12):1267-1269. 被引量:5
  • 3Ferrandina G, Lauriola L, Distefano MG, et al. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. Clin Oncol, 2002,20 : 973-981.
  • 4Kugler A. Matrix metalloproteinases and their inhibitors. Anticancer Res, 1999,19: 1589-1592.
  • 5Hickey M, Crewe J, Mahoney L A, et al. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors. Clin Endocrinol Metab, 2006,91 : 3189-3198.
  • 6determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. Clin Oncol, 1995,13 : 765-782.
  • 7Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res, 2002,62 : 632-635.
  • 8Yu HG, Li JY, Yang YN, et al. Increased abundance of cyclooxygenase-2 correlateswith vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett, 2003,195:43-51.
  • 9Joo YE, Rew JS, Seo YH, et al. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. Clin Gastroenterol, 2003,37 : 28-33.
  • 10Xi H, Baldus SE, Warnecke-Eberz U, et al. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy Is Associated with Minor Histopathologic response and poor prognosis in esophageal cancer. Clin Cancer Res, 2005,11 : 8341-8347.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部